Trajectories of functioning in bipolar disorders: A longitudinal study in the FondaMental Advanced Centers of Expertise in Bipolar Disorders cohort.


Journal

The Australian and New Zealand journal of psychiatry
ISSN: 1440-1614
Titre abrégé: Aust N Z J Psychiatry
Pays: England
ID NLM: 0111052

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 12 8 2020
medline: 19 8 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

We aimed at identifying distinct trajectories of functioning and at describing their respective clinical characteristics in a cohort of individuals with bipolar disorders. We included a sample of 2351 individuals with bipolar disorders who have been followed-up to 3 years as part as the FondaMental Advanced Centers of Expertise in Bipolar Disorders cohort. Global functioning was measured using the Functioning Assessment Short Test. We used latent class mixed models to identify distinct longitudinal trajectories of functioning over 3 years. Multivariable logistic regression models were used to identify the baseline factors that were associated with the membership to each trajectory of functioning. Three distinct trajectories of functioning were identified: (1) a majority of individuals (72%) had a stable trajectory of mild functional impairment, (2) 20% of individuals had a stable trajectory of severe functional impairment and (3) 8% of individuals had a trajectory of moderate functional impairment that improved over time. The membership to a trajectory of stable severe versus stable mild functional impairment was associated with unemployment, a higher number of previous hospitalizations, childhood maltreatment, a higher level of residual depressive symptoms, higher sleep disturbances, a higher body mass index and a higher number of psychotropic medications being prescribed at baseline. The model that included these seven factors led to an area under the curve of 0.85. This study enabled to stratify individuals with bipolar disorders according to three distinct trajectories of functioning. The results regarding the potential determinants of the trajectory of severe functional impairment needs to be replicated in independent samples. Nevertheless, these potential determinants may represent possible therapeutic targets to improve the prognosis of those patients at risk of persistent poor functioning.

Identifiants

pubmed: 32779531
doi: 10.1177/0004867420945796
doi:

Substances chimiques

Psychotropic Drugs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

985-996

Investigateurs

E Haffen (E)
P M Llorca (PM)
V Barteau (V)
S Bensalem (S)
M Laaidi (M)
H Laouamri (H)
K Souryis (K)
S Hotier (S)
A Pelletier (A)
N Drancourt (N)
J P Sanchez (JP)
E Saliou (E)
C Hebbache (C)
J Petrucci (J)
L Willaume (L)
E Bourdin (E)
M Carminati (M)
B Etain (B)
E Marlinge (E)
J Meheust (J)
B Antoniol (B)
A Desage (A)
S Gard (S)
A Jutant (A)
K Mbailara (K)
I Minois (I)
L Zanouy (L)
C Abettan (C)
L Bardin (L)
A Cazals (A)
B Deffinis (B)
D Ducasse (D)
M Gachet (M)
A Henrion (A)
E Martinerie (E)
F Molière (F)
B Noisette (B)
G Tarquini (G)
R Belzeaux (R)
N Correard (N)
J L Consoloni (JL)
F Groppi (F)
L Lescalier (L)
J Montant (J)
M Rebattu (M)
N Viglianese (N)
R Cohen (R)
M Milazzo (M)
O Wajsbrot-Elgrabli (O)
T Bougerol (T)
B Fredembach (B)
S Garçon (S)
P Grignon (P)
A Perrin (A)
A M Galliot (AM)
I Grévin (I)
A S Cannavo (AS)
N Kayser (N)
P Roux (P)
V Aubin (V)
I Cussac (I)
M A Dupont (MA)
I Medecin (I)
N Mazer (N)
C Portalier (C)

Auteurs

Ophelia Godin (O)

Fondation FondaMental, Créteil, France.
Université Paris Est Créteil, Inserm U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Créteil, France.
AP-HP, HU Henri Mondor, Departement Medico-Universitaire de Psychiatrie et d'Addictologie (DMU ADAPT), Federation Hospitalo-Universitaire de Médecine de Precision (FHU IMPACT), Paris, France.

Marion Leboyer (M)

Fondation FondaMental, Créteil, France.
Université Paris Est Créteil, Inserm U955, IMRB, Laboratoire Neuro-Psychiatrie Translationnelle, Créteil, France.
AP-HP, HU Henri Mondor, Departement Medico-Universitaire de Psychiatrie et d'Addictologie (DMU ADAPT), Federation Hospitalo-Universitaire de Médecine de Precision (FHU IMPACT), Paris, France.

Yassin Mazroui (Y)

Laboratoire de Probabilités, Statistiques et Modélisation (LPSM), Sorbonne Université, Paris, France.

Bruno Aouizerate (B)

Fondation FondaMental, Créteil, France.
Centre Expert Troubles Bipolaires, Service de Psychiatrie Adulte, Hôpital Charles-Perrens, Bordeaux, France.

Jean-Michel Azorin (JM)

Fondation FondaMental, Créteil, France.
Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France.
CNRS Aix-Marseille Université, Marseille, France.

Belzeaux Raoul (B)

Fondation FondaMental, Créteil, France.
Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France.
CNRS Aix-Marseille Université, Marseille, France.

Frank Bellivier (F)

Fondation FondaMental, Créteil, France.
Assistance Publique des Hôpitaux de Paris (AP-HP), GHU Saint-Louis-Lariboisière-Fernand Widal, DMU Neurosciences, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS 1144, Université de Paris, Paris, France.

Mircea Polosan (M)

Fondation FondaMental, Créteil, France.
Université Grenoble Alpes, CHU de Grenoble et des Alpes, Grenoble Institut des Neurosciences (GIN) Inserm U1216, Grenoble, France.

Philippe Courtet (P)

Fondation FondaMental, Créteil, France.
Département Urgence et Post-urgence Psychiatrique, CHU Montpellier, INSERM U1061, Université de Montpellier, Montpellier, France.

Caroline Dubertret (C)

Fondation FondaMental, Créteil, France.
AP-HP, Groupe Hospitalo-Universitaire Nord, DMU ESPRIT, Service de Psychiatrie et Addictologie, Hopital Louis Mourier, Colombes, Inserm U1266, Faculté de Médecine, Université de Paris, Paris, France.

Chantal Henry (C)

Fondation FondaMental, Créteil, France.
Department of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, Paris, France.

Jean-Pierre Kahn (JP)

Fondation FondaMental, Créteil, France.
Université de Lorraine, CHRU de Nancy et Pôle de Psychiatrie et Psychologie Clinique, Centre Psychothérapique de Nancy, Nancy, France.

Josephine Loftus (J)

Fondation FondaMental, Créteil, France.
Pôle de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, France.

Emilie Olié (E)

Fondation FondaMental, Créteil, France.
Département Urgence et Post-urgence Psychiatrique, CHU Montpellier, INSERM U1061, Université de Montpellier, Montpellier, France.

Christine Passerieux (C)

Fondation FondaMental, Créteil, France.
Service Universitaire de Psychiatrie d'Adultes, Centre Hospitalier de Versailles, Le Chesnay, Université Paris-Saclay, UVSQ, Inserm, CESP, Team 'DevPsy', Villejuif, France.

Dominique Costagliola (D)

INSERM, Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.

Bruno Etain (B)

Fondation FondaMental, Créteil, France.
Assistance Publique des Hôpitaux de Paris (AP-HP), GHU Saint-Louis-Lariboisière-Fernand Widal, DMU Neurosciences, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS 1144, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH